ArticleJournal of gastroenterology and hepatology2025

Hypertension as an Adverse Event Potentially Impacting the Therapeutic Efficacy of Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma.

Kazuki Maesaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.